Severity
Low
FDA Drug recall · Reported April 14, 2021
Failed Moisture Limits: Out of specification for water content
Sun Pharmaceutical Industries INC recalled Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, … - a low-severity action.
Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, … was recalled by Sun Pharmaceutical Industries INC in April 14, 2021. Reason: Failed Moisture Limits: Out of specification for water content. Check the official notice for the remedy. Verify recall #D-0325-2021 with the FDA Drug before acting.
The recall
Sun Pharmaceutical Industries INC issued this low-severity FDA Drug recall-Failed Moisture Limits: Out of specification for water content.
Sourced from official FDA Drug enforcement records. Verify recall #D-0325-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0325-2021) was formally reported on April 14, 2021, with the manufacturer initiating the action on March 25, 2021. It is classified under Low severity (Class III), with a current status of Terminated. Sun Pharmaceutical Industries INC is listed as the recalling firm, operating out of Princeton, NJ. Federal records list the affected scope as 2520 bottles.
The documented reason for this recall is: Failed Moisture Limits: Out of specification for water content Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
2520 bottles
Related Recalls
6
5 from same agency
Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda HIghway, Halol-389 350 Gujarat, India, NDC 62756-142-02.
Failed Moisture Limits: Out of specification for water content
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0325-2021 |
| Date reported | April 14, 2021 |
| Date initiated | March 25, 2021 |
| Recalling firm | Sun Pharmaceutical Industries INC |
| Firm location | Princeton, NJ |
| Affected scope | 2520 bottles |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 14, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.